Chai et al. [73] suggested that IL-37 has a significant role in atherosclerosis, demonstrating in apoE-deficient diabetic mice that IL-37 treatment significantly reduced vascular calcification and atherosclerosis progression. The gene discussed is IL37; the disease is atherosclerosis.